Growth Metrics

Synopsys (SNPS) Cash & Equivalents (2016 - 2026)

Synopsys filings provide 18 years of Cash & Equivalents readings, the most recent being $43.1 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 98.82% to $43.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $43.1 million through Jan 2026, down 98.82% year-over-year, with the annual reading at $2.9 billion for FY2025, 25.92% down from the prior year.
  • Cash & Equivalents hit $43.1 million in Q1 2026 for Synopsys, down from $2.9 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $14.1 billion in Q2 2025 and bottomed at $43.1 million in Q1 2026.
  • Average Cash & Equivalents over 5 years is $2.5 billion, with a median of $1.6 billion recorded in 2022.
  • The largest annual shift saw Cash & Equivalents skyrocketed 838.02% in 2025 before it crashed 98.82% in 2026.
  • Synopsys' Cash & Equivalents stood at $1.4 billion in 2022, then grew by 11.67% to $1.6 billion in 2023, then surged by 145.88% to $3.9 billion in 2024, then fell by 25.92% to $2.9 billion in 2025, then crashed by 98.51% to $43.1 million in 2026.
  • Per Business Quant, the three most recent readings for SNPS's Cash & Equivalents are $43.1 million (Q1 2026), $2.9 billion (Q4 2025), and $2.6 billion (Q3 2025).